ITA
ENG
Home
Clinical Cases
Job opportunities Italia
INFORMATIVA SUL TRATTAMENTO DEI DATI PERSONALI
Chiesi clinical trial data request portal
About us
History
Mission and Values
Management
Annual Report and CSR
Our affiliates
Our partners
Therapeutic areas
Respiratory
PRIMARY CARE
Neonatology
Rare Diseases
Special care
Contact
Research and Development
Pipeline
Clinical Trial Transparency and Data Sharing
Production plants
Parma
Blois
Santana de Parnaíba
Global Corporate Development
What we are looking for
Who we are
Where we are
Submit your idea
News & Events
Chiesi Ventures
Sustainability
Sustainability at Chiesi
We ACT - Sustainability Manifesto
Ethics
Transparency
People at the centre
Environment
Community
Chiesi Foundation Onlus
Sustainability report
Working at Chiesi
People at the centre
Young graduates and post graduated
Experienced professionals
Meet our people
Job opportunities
Tips
F.A.Q.
Media area
News
Press Release
Enter at least 3 characters
Home
|
Contact
|
Pharmacovigilance
|
ITA
ENG
Welcome to
Chiesi group
Enter at least 3 characters
About us
History
Mission and Values
Management
Annual Report and CSR
Our affiliates
Our partners
Therapeutic areas
Respiratory and Primary care
Neonatology
Rare Diseases and Special care
Research and Development
Pipeline
Clinical Trial Transparency and Data Sharing
Production plants
Parma
Blois
Santana de Parnaíba
Global Corporate Development
What we are looking for
Who we are
Where we are
Submit your idea
News & Events
Chiesi Ventures
Sustainability
Sustainability at Chiesi
We ACT - Sustainability Manifesto
Ethics
Transparency
People at the centre
Environment
Community
Chiesi Foundation Onlus
Sustainability report
Working at Chiesi
People at the centre
Young graduates and post graduated
Experienced professionals
Meet our people
Job opportunities
Tips
F.A.Q.
Media area
News
Press Release
This site uses cookies. Continuing to navigate is considered accepted usage.
More info
CLOSE
Respiratory
Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people...
Respiratory
Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people...
Neonatology
Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the...
Neonatology
Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the...
Rare Diseases
Rare Diseases The term rare applies to those diseases affecting a limited number of people with...
Rare Diseases
Rare Diseases The term rare applies to those diseases affecting a limited number of people with...
08
02/19
NEWS
Chiesi: “imprese per innovazione” award, Industry 4.0 and Sustainability...
Chiesi received the "Imprese per innovazione" award during the Connext event of February 6 and 7. Connext is the first National...
PRESS RELEASE
Chiesi Group receives the EURORDIS Black Pearl Award for innovation in the...
Brussels, February 13, 2019 – Chiesi, an international research-focused healthcare Group (Chiesi Group), was awarded...
Global Corporate Development
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.
